Experience
飛翰代表國際中橡取得$1.8 億美元之複雜仲裁案件和解金
Genzyme Corp.
CSRC et al.
國際中橡投資控股股份有限公司及其子公司專屬授權Genzyme數個和治療龐貝氏症有關的歐洲和美國專利,龐貝氏症是一種不予治療通常會致命的遺傳性罕見疾病。Genzyme依該授權及市場獨佔性,銷售唯一獲得美國食品藥品監督管理局批准的龐貝氏症治療藥物,據報年營收達數億美元。Genzyme向美國仲裁協會提出仲裁之申請,辯稱其於歐洲地區權利金給付之義務已停止,以及美國權利金給付義務應在最後一個被授權專利到期日的約莫兩年前即終止。國際中橡連帶對杜克大學提告,因為杜克大學未將國際中橡贊助之治療龐貝氏症研究有關的某些專利讓與國際中橡。國際中橡和Genzyme就美國仲裁協會受理的仲裁案件簽署和解協議,Genzyme同意支付 1.8 億美元的爭議妥協和解金。
Genzyme Corp. v. CSRC et al., 01-19-0001-6937; 01-20-0000-5081, American Arbitration Association (AAA)
Finnegan revives key Jublia® patent at the Federal Circuit
Kaken Pharmaceutical Co., Ltd.; Bausch Health Care
Copyright victory on summary judgment and appeal for Dean Guitars and Estate of Pantera guitarist
Dean Guitars; Armadillo Enterprises, Inc.; Armadillo Distribution Enterprises, Inc.; Estate of Dimebag Darrell Abbott; Does 4-10; and Guitar Center, Inc.
Clean sweep at the PTAB for SharkNinja
SharkNinja Operating LLC et al
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Federal Circuit upholds enhanced damages award to Finnegan client WCM Industries
WCM Industries, Inc.
Delta Faucet Company v. Globe Union Industrial Corp. et al.
Globe Union Industrial Corp.
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
Novartis Gene Therapies, Inc. et al.
Boston Scientific Corp. et al. v. Cook, Inc. et al.
Boston Scientific Corp. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.